DST Capital LLC Ups Stake in Harvard Apparatus Regenerative Tech

TL;DR

DST Capital just bought more Harvard Apparatus stock, now owns 10.4%.

AI Summary

DST Capital LLC filed an amendment (Amendment No. 10) to its Schedule 13D on August 16, 2024, regarding its holdings in Harvard Apparatus Regenerative Technology, Inc. The filing indicates a change in beneficial ownership, with DST Capital LLC now holding 1,480,000 shares of common stock, representing approximately 10.4% of the outstanding shares. This filing follows a previous amendment on August 15, 2024, where DST Capital LLC reported holding 1,470,000 shares.

Why It Matters

This filing signals increased conviction from a significant shareholder in Harvard Apparatus Regenerative Technology, Inc., potentially influencing stock price and strategic decisions.

Risk Assessment

Risk Level: medium — Changes in beneficial ownership by significant holders can introduce volatility and uncertainty regarding the company's future direction.

Key Numbers

• 1,480,000 — Shares Owned (Total shares of common stock held by DST Capital LLC as of August 16, 2024.)
• 10.4% — Ownership Percentage (Percentage of outstanding common stock owned by DST Capital LLC.)
• 20240816 — Filing Date (Date of the Schedule 13D/A filing.)

Key Players & Entities

• DST Capital LLC (company) — Filing entity
• Harvard Apparatus Regenerative Technology, Inc. (company) — Subject company
• Biostage, Inc. (company) — Former name of subject company
• Josef Volman, Esq. (person) — Legal counsel
• Blank Rome (company) — Legal firm

FAQ

Key Financial Figures

• $0.01 — nc.) (Name of Issuer) Common Stock, $0.01 par value (Title of Class of Securiti
• $8.88 — ,139 warrants with an exercise price of $8.88. Except as specifically provided herein
• $2.00 — Common Stock with an exercise price of $2.00 per share and another warrant assignmen

Filing Documents

• formsc13da.htm (SC 13D/A) — 105KB
• 0001493152-24-032850.txt ( ) — 107KB

)*

Item 5)* 14 TYPE OF REPORTING PERSON IN *As more fully described in Item 5, 4,139 of the warrants are subject to a 4.99% blocker, and the percentage set forth in row (13) gives effect to such blockers. However, as more fully described in Item 5, the securities reported in rows (8), (10) and (11) show the number of shares of common stock that would be issuable upon full exercise of such reported securities and do not give effect to such blockers. Therefore, the actual number of shares of common stock beneficially owned by such reporting person, after giving effect to such blockers, is less than the number of securities reported in rows (8), (10) and (11). CUSIP No. 09074M 202 13D Page 3 of 5 Item 1. Security and Issuer. This Amendment No. 10 amends and supplements the statement on Schedule 13D originally filed with the SEC by DST Capital LLC, Polyvia LLC, Jing Chen, Jiong Shao, and Bin Zhao on January 10, 2018 (the “Original 13D”), as amended by Amendment No. 1 on July 6, 2018, Amendment No. 2 on February 20, 2019, Amendment No. 3 on May 13, 2019 that disclaimed and evidenced the termination of any joint filing arrangement or agreement with respect to reporting persons included in the Original Schedule 13D other than DST Capital LLC and Bin Zhao, Amendment No. 4 on September 5, 2019, Amendment No. 5 on December 19, 2019, Amendment No. 6 on April 23, 2020, Amendment No. 7 on September 16, 2020, Amendment No. 8 on June 23, 2021 and Amendment No. 9 on September 10, 2021 (“Amendment No. 9”), and relates to the common stock, $0.01 par value (the “Common Stock”) of Harvard Apparatus Regenerative Technology, Inc., formally known as Biostage, Inc. (the “Issuer”), having its principal executive office at 84 October Hill Road, Suite 11, Holliston, MA 01746. This Amendment No. 10 is being filed to update the number and percentage of Common Stock of the Issuer beneficially owned by DST Capital LLC as a result of t

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of its knowledge and belief, each of the undersigned certifies that the information set forth in this Dated: August 16, 2024 DST CAPITAL LLC By: /s/ Bin Zhao Bin Zhao, Owner /s/ Bin Zhao Bin Zhao

View Full Filing

View this SC 13D/A filing on SEC EDGAR